ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $514K of Zentalis Pharmaceuticals, Inc.
Sold$514,334
$51.43Price
10,000Shares
−2%Stake
What ZNTL did after the filing
- The stock from Thu, Dec 3 close, $51.27
- −4.0%
- S&P 500, same days
- +3.7%
Measured over 30 trading days, to the Jan 19 close.
Traded Wed, Dec 2. Filed Thu, Dec 3, 12:56 PM ET, during the session. Returns use the Dec 3 close and the Jan 19 close. Not investment advice.